Deadline: December 23, 2027

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. Offered by National Institutes of Health; applications due December 23, 2027.

Key Facts

Funder
National Institutes of Health
Award amount
Not specified by funder
Deadline
December 23, 2027
Geography
United States
Categories
Research
Status
Open

About This Grant

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Product Definition initiative will provide the early stage translational support needed for the activities required to develop and...

Full requirements and application instructions: official listing.

Similar Open Grants

Due August 7, 2026$3.5M

Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)

National Institutes of Health

Due September 28, 2026$10.0M

Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)

National Institutes of Health

Due October 2, 2026$2.0M

Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)

National Institutes of Health

Due October 2, 2026$575K

Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)

National Institutes of Health

Due October 9, 2026$300K

Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)

National Institutes of Health

Due October 19, 2026

Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)

National Institutes of Health

Due December 23, 2027

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

National Institutes of Health

Due December 31, 2027$0

NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements

National Park Service

Due January 4, 2028

DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH

Dept of the Army -- Materiel Command

Due January 6, 2028

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

National Institutes of Health

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.